4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000030
Chief Medical Officer sold 8,519 shares at an average $24.20 ($206,151)
- Chief Medical Officer acquired 8,519 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-06-10 | Option exercise 10b5-1 | +2,170 | $16.00 | $34,720 | 65,613 | D |
| Rodman David Malcom Chief Medical Officer | 2026-06-10 | Sale 10b5-1 | −2,170 | $25.00 | $54,250 | 63,443 | D |
| Rodman David Malcom Chief Medical Officer | 2026-06-12 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 69,792 | D |
| Rodman David Malcom Chief Medical Officer | 2026-06-12 | Sale 10b5-1 | −6,349 | $23.93 | $151,901 | 63,443 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-06-10 | Option exercise · Stock Option 10b5-1 | −2,170 | 17,365 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-06-12 | Option exercise · Stock Option 10b5-1 | −6,349 | 6,349 | D | ||
| Open-market sales · 8,519 sh · avg $24.20 · $206,151 | |||||||
Loading xslF345X06/wk-form4_1781301893.xml…